Cantor Fitzgerald Starts Jazz Pharmaceuticals (JAZZ) at Buy; Generic Worries Misplaced
Tweet Send to a Friend
Cantor Fitzgerald initiates coverage on Jazz Pharmaceuticals (NASDAQ: JAZZ) with a Buy. PT $86.00.
The firm said Jazz is ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
The firm said Jazz is ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
